Efficacy and Safety of Bimekizumab in Patients With Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial
J Am Acad Dermatol 2023 May 12;[EPub Ahead of Print], B Strober, C Paul, A Blauvelt, D Thaçi, L Puig, M Lebwohl, K White, V Vanvoorden, D Deherder, NN Gomez, K EyerichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.